ATR AND DNA-PK/CHK1 ELICIT DISTINCT RESPONSES IN CANCER CELLS

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 11期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1123 / 1123
页数：1
相关论文
共 50 条
  • [21] DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?
    Durocher, D
    Jackson, SP
    CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (02) : 225 - 231
  • [22] Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress
    Liu, Shengqin
    Opiyo, Stephen O.
    Manthey, Karoline
    Glanzer, Jason G.
    Ashley, Amanda K.
    Amerin, Courtney
    Troksa, Kyle
    Shrivastav, Meena
    Nickoloff, Jac A.
    Oakley, Greg G.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (21) : 10780 - 10794
  • [23] DNA-PK, ATM, and ATR: PIKKing on p53
    Ashley, Amanda K.
    Kemp, Christopher J.
    CELL CYCLE, 2018, 17 (03) : 275 - 276
  • [24] ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK
    Hall-Jackson, CA
    Cross, DAE
    Morrice, N
    Smythe, C
    ONCOGENE, 1999, 18 (48) : 6707 - 6713
  • [25] ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK
    Clare A Hall-Jackson
    Darren AE Cross
    Nick Morrice
    Carl Smythe
    Oncogene, 1999, 18 : 6707 - 6713
  • [26] Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
    Xinhui Zhou
    Weijin Liu
    Xing Hu
    Adrienne Dorrance
    Ramiro Garzon
    Peter J. Houghton
    Changxian Shen
    Scientific Reports, 7
  • [27] Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
    Zhou, Xinhui
    Liu, Weijin
    Hu, Xing
    Dorrance, Adrienne
    Garzon, Ramiro
    Houghton, Peter J.
    Shen, Changxian
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
    Jayakumar Nair
    Tzu-Ting Huang
    Junko Murai
    Brittany Haynes
    Patricia S. Steeg
    Yves Pommier
    Jung-Min Lee
    Oncogene, 2020, 39 : 5520 - 5535
  • [29] Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
    Nair, Jayakumar
    Huang, Tzu-Ting
    Murai, Junko
    Haynes, Brittany
    Steeg, Patricia S.
    Pommier, Yves
    Lee, Jung-Min
    ONCOGENE, 2020, 39 (33) : 5520 - 5535
  • [30] Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
    Sanjiv, Kumar
    Hagenkort, Anna
    Calderon-Montano, Jose Manuel
    Koolmeister, Tobias
    Reaper, Philip M.
    Mortusewicz, Oliver
    Jacques, Sylvain A.
    Kuiper, Raoul V.
    Schultz, Niklas
    Scobie, Martin
    Charlton, Peter A.
    Pollard, John R.
    Berglund, Ulrika Warpman
    Altun, Mikael
    Helleday, Thomas
    CELL REPORTS, 2016, 14 (02): : 298 - 309
12345